[1]
Chiang-ngernthanyakun, K. 2021. Sodium Glucose Cotransporter 2 Inhibitor and Glucagon-like Peptide 1 Receptor Agonist: New Glucose-lowering Medications and Cardiovascular Outcome. Chiang Mai Dental Journal. 42, 1 (Apr. 2021), 199–215.